Mathieu, Chantal
KU Leuven
59 papers on CoChatORCID 0000-0002-4055-5233
Most cited papers
- Verified
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
Mathieu, C., Hollander, P., Miranda-Palma, B., Cooper, J., Franek, E., Russell-Jones, D., Larsen, J., Tamer, S. C., Bain, S. C., & on behalf of the NN1250-3770 (BEGIN: Flex T1) Trial Investigators (2013) · The Journal of Clinical Endocrinology & Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 219
- Verified
Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: A real-world study
Charleer, S., Mathieu, C., Nobels, F., De Block, C., Radermecker, R. P., Hermans, M. P., Taes, Y., Vercammen, C., T'Sjoen, G., Crenier, L., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism
Diabetes Management and ResearchDiabetes Management and Education
Cited by 196
- Verified
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled, phase 2 trial
von Herrath, M., Bain, S. C., Bode, B., Clausen, J. O., Coppieters, K., Gaysina, L., Gumprecht, J., Hansen, T. K., Mathieu, C., Morales, C., et al. (2021) · The Lancet Diabetes & Endocrinology
Diabetes and associated disordersPancreatic function and diabetes
Cited by 186
- Verified
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.
Reichman, T. W., Markmann, J. F., Odorico, J., Witkowski, P., Fung, J. J., Wijkstrom, M., Kandeel, F., de Koning, E. J. P., Peters, A. L., Mathieu, C., et al. (2025) · New England Journal of Medicine
Pancreatic function and diabetesDiabetes and associated disorders
Cited by 177
- Verified
Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: Results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (ONSET 1)
Russell-Jones, D., Bode, B. W., De Block, C., Franek, E., Heller, S. R., Mathieu, C., Philis-Tsimikas, A., Rose, L., Woo, V. C., Østerskov, A. B., et al. (2017) · Diabetes Care
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 177
- Verified
Factors associated with diabetes-specific health-related quality of life in youth with type 1 diabetes: the Global TEENs Study
Anderson, B. J., Laffel, L. M., Domenger, C., Danne, T., Phillip, M., Mazza, C., Hanas, R., Waldron, S., Beck, R. W., Calvi-Gries, F., et al. (2017) · Diabetes Care
Diabetes Management and EducationDiabetes Management and Research
Cited by 170
- Verified
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial
Visser, M. M., Charleer, S., Fieuws, S., De Block, C., Hilbrands, R., Van Huffel, L., Maes, T., Vanhaverbeke, G., Dirinck, E., Myngheer, N., et al. (2021) · The Lancet
Diabetes Management and ResearchDiabetes Management and Education
Cited by 165
- Verified
Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease
Muscogiuri, G., Mitri, J., Mathieu, C., Badenhoop, K., Tamer, G., Orio, F., Mezza, T., Vieth, R., Colao, A., & Pittas, A. (2014) · European Journal of Endocrinology
Vitamin D Research StudiesParathyroid Disorders and Treatments
Cited by 157
- Verified · note
The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000
Weets, I., De Leeuw, I. H., Du Caju, M. V. L., Rooman, R., Keymeulen, B., Mathieu, C., Rottiers, R., Daubresse, J.-C., Rocour-Brumioul, D., Pipeleers, D. G., et al. (2002) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 137
- Verified
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial
Benhalima, K., Beunen, K., Van Wilder, N., Ballaux, D., Vanhaverbeke, G., Taes, Y., Aers, X.-P., Nobels, F., Marlier, J., Lee, D., et al. (2024) · The Lancet Diabetes & Endocrinology
Diabetes Management and ResearchGestational Diabetes Research and Management
Cited by 131
- Verified
Death Protein 5 and p53-Upregulated Modulator of Apoptosis Mediate the Endoplasmic Reticulum Stress–Mitochondrial Dialog Triggering Lipotoxic Rodent and Human β-Cell Apoptosis
Cunha, D. A., Igoillo-Esteve, M., Gurzov, E. N., Germano, C. M., Naamane, N., Marhfour, I., Fukaya, M., Vanderwinden, J.-M., Gysemans, C., Mathieu, C., et al. (2012) · Diabetes
Endoplasmic Reticulum Stress and DiseasePancreatic function and diabetes
Cited by 130
- Verified
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
Russell-Jones, D., Babazono, T., Cailleteau, R., Engberg, S., Irace, C., Kjaersgaard, M. I. S., Mathieu, C., Rosenstock, J., Woo, V., & Klonoff, D. C. (2023) · The Lancet
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 115
- Verified
Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study
Barker, A., Lauria, A., Schloot, N., Hosszufalusi, N., Ludvigsson, J., Mathieu, C., Mauricio, D., Nordwall, M., Van der Schueren, B., Mandrup‐Poulsen, T., et al. (2014) · Diabetes, Obesity and Metabolism
Diabetes and associated disordersDiabetes Management and Research
Cited by 101
- Verified
Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial
Mathieu, C., Bode, B. W., Franek, E., Philis‐Tsimikas, A., Rose, L., Graungaard, T., Birk Østerskov, A., & Russell‐Jones, D. (2018) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 95
- Verified
Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes
Fulcher, G., Matthews, D. R., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Mathieu, C., Woo, V., Wysham, C., Capuano, G., Desai, M., et al. (2016) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 91
- Verified
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Phillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E., Colhoun, H. M., Couper, J. J., et al. (2024) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 79
- Verified
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
Groop, P.-H., Dandona, P., Phillip, M., Gillard, P., Edelman, S., Jendle, J., Xu, J., Scheerer, M. F., Thoren, F., Iqbal, N., et al. (2020) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 79
- Verified
Analysis of pregnancy outcomes using the new IADPSG recommendation compared with the Carpenter and Coustan criteria in an area with a low prevalence of gestational diabetes
Benhalima, K., Hanssens, M., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2013) · International Journal of Endocrinology
Gestational Diabetes Research and ManagementMaternal and Perinatal Health Interventions
Cited by 73
- Verified
A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)
Benhalima, K., Mathieu, C., Damm, P., Van Assche, A., Devlieger, R., Desoye, G., Corcoy, R., Mahmood, T., Nizard, J., Savona-Ventura, C., et al. (2015) · Diabetologia
Gestational Diabetes Research and ManagementDiabetes Management and Research
Cited by 72
- Verified
Survey by the European Board and College of Obstetrics and Gynaecology on screening for gestational diabetes in Europe
Benhalima, K., Mathieu, C., Van Assche, A., Damm, P., Devlieger, R., Mahmood, T., & Dunne, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology
Gestational Diabetes Research and ManagementDiabetes Management and Research
Cited by 63
- Verified
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial
Heerspink, H. J. L., Birkenfeld, A. L., Cherney, D. Z. I., Colhoun, H. M., Ji, L., Mathieu, C., Groop, P.-H., Pratley, R. E., Rosas, S. E., Rossing, P., et al. (2023) · Diabetes Research and Clinical Practice
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 63
- Verified
Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · European Journal of Endocrinology
Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 60
- Verified
Differences in pregnancy outcomes and characteristics between insulin- and diet-treated women with gestational diabetes
Benhalima, K., Robyns, K., Van Crombrugge, P., Deprez, N., Seynhave, B., Devlieger, R., Verhaeghe, J., Mathieu, C., & Nobels, F. (2015) · BMC Pregnancy and Childbirth
Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 55
- Verified
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis
Takele, W. W., Vesco, K. K., Josefson, J., Redman, L. M., Hannah, W., Bonham, M. P., Chen, M., Chivers, S. C., Fawcett, A. J., Grieger, J. A., et al. (2024) · Communications Medicine
Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free